Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Hemasphere|January 25, 2020
Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating SignalingTom Hofland, Sanne Endstra, Calum K P Gomes, et al.
Journal for Immunotherapy of Cancer|April 18, 2023
Ectopic expression of cGAS in <i>Salmonella typhimurium</i> enhances STING-mediated IFN-β response in human macrophages and dendritic cellsLisette Waanders, Lieve E H van der Donk, Louis S Ates, et al.
European Journal of Immunology|October 24, 2020
Human CXCR5<sup>+</sup> PD-1<sup>+</sup> CD8 T cells in healthy individuals and patients with hematologic malignanciesTom Hofland, Anne W J Martens, Jaco A C van Bruggen, et al.
Hemasphere|January 29, 2026
IL21-STAT3 controls the pentose phosphate pathway to support metabolic reprogramming and tumor progression in chronic lymphocytic leukemiaRosita Del Prete, Vjola Tusha, Helga Simon-Molas, et al.
Plos Biology|March 18, 2020
Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinityInga Kavazović, Hongya Han, Giulia Balzaretti, et al.
Blood|October 9, 2013
Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse modelValeria Lascano, Marco Guadagnoli, Jan G Schot, et al.
Kidney International|June 1, 2012
Viral double-stranded RNA sensors induce antiviral, pro-inflammatory, and pro-apoptotic responses in human renal tubular epithelial cellsKirstin M Heutinck, Ajda T Rowshani, Jorien Kassies, et al.
Blood Advances|July 23, 2024
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cellsJaco A C van Bruggen, Fleur S Peters, Morris Mes, et al.
Leukemia Research|November 19, 2013
Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 studyArnon P Kater, Marjolein Spiering, Roberto D Liu, et al.
Cancer Research|December 17, 2008
In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrowRogier van Gent, Arnon P Kater, Sigrid A Otto, et al.
Pageof 12